Pharmaceutical funds have emerged the worst performers among sectoral ones in the past year, trailing other categories such as banking, information technology (IT), fast moving consumer goods (FMCG) and infrastructure. In a year, pharma funds have shed 8.5 per cent, shows data from Value Research. In this period, the benchmark BSE Sensex has returned 16 per cent, implying these funds have underperformed the market by nearly 25 per cent.
75 years to reach per capita income of $2730, will take only 5 years to add another $2000, FM Sitharaman
Read More